News from Weill Cornell Medical College
Epigenetic Factor Likely Plays a Key Role in Fueling Most Common Childhood Cancer
June 13, 2013 Changes in an epigenetic mechanism that turns expression of genes on and off may be as important as genetic alterations in causing pediatric acute lymphoblastic leukemia (ALL), according to a study led by scientists at St. Jude Children's Research Hospital and Weill Cornell Medical College and published in the June 10 online edition of the Journal of Clinical Investigation. [more]
More Press Releases
Center for Autism and the Developing Brain Set to Open at NewYork-Presbyterian Hospital
June 10, 2013 NewYork-Presbyterian Hospital, along with its affiliated medical schools, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, today celebrated the dedication of its new Center for Autism and the Developing Brain, located at the hospital's Westchester campus in White Plains. Developed in collaboration with New York Collaborates for Autism, the 11,000-square-foot facility will provide comprehensive services to people with autism spectrum disorders at every stage of life, from infancy through adulthood.
June 10, 2013 NewYork-Presbyterian Hospital, along with its affiliated medical schools, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, today celebrated the dedication of its new Center for Autism and the Developing Brain, located at the hospital's Westchester campus in White Plains. Developed in collaboration with New York Collaborates for Autism, the 11,000-square-foot facility will provide comprehensive services to people with autism spectrum disorders at every stage of life, from infancy through adulthood.
Scientists, Biotech Industry and Investors Join Forces in Second Annual Brain Tumor Biotech Summit at Weill Cornell Medical College
June 7, 2013 The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
June 7, 2013 The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
